Details for New Drug Application (NDA): 203711
✉ Email this page to a colleague
The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Summary for 203711
Tradename: | ONDANSETRON HYDROCHLORIDE |
Applicant: | Qilu Pharm Hainan |
Ingredient: | ondansetron hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 203711
Mechanism of Action | Serotonin 3 Receptor Antagonists |
Suppliers and Packaging for NDA: 203711
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 203711 | ANDA | Henry Schein, Inc. | 0404-9930 | 0404-9930-02 | 1 VIAL, SINGLE-USE in 1 BAG (0404-9930-02) / 2 mL in 1 VIAL, SINGLE-USE |
ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 203711 | ANDA | A-S Medication Solutions | 50090-4935 | 50090-4935-0 | 25 VIAL, SINGLE-USE in 1 CARTON (50090-4935-0) / 2 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Sep 8, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription